AADi
医疗健康
项目属于 AADi is a clinical stage biopharmaceutical company led by Dr. Neil Desai, an inventor of Abraxane®, ABI-009 and the nab® technology platform. Aadi’s lead product is ABI-009, a nanoparticle albumin-bound mTOR inhibitor based on sirolimus or rapamycin, also known as nab-rapamycin. 详细介绍点此可网络搜索更多。